Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 30 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

30%

9 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

9 recruiting1 with results

Enrollment Performance

Analytics

N/A
10(41.7%)
Phase 3
5(20.8%)
Phase 2
5(20.8%)
Phase 4
4(16.7%)
24Total
N/A(10)
Phase 3(5)
Phase 2(5)
Phase 4(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (30)

Showing 20 of 30 trials
NCT04078568Phase 3Completed

Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease

Role: collaborator

NCT02405676Phase 2Active Not Recruiting

BNHL-2015 for Children or Adolescents in China

Role: collaborator

NCT02845882Phase 3Active Not Recruiting

LBL-2016 for Children or Adolescents in China

Role: collaborator

NCT07476625Not ApplicableNot Yet Recruiting

Efficacy and Safety of Thalidomide for Pediatric PFAPA Syndrome

Role: collaborator

NCT07420504Not ApplicableNot Yet Recruiting

A Longitudinal Study of Parental Sleep Intervention for Behavioral Insomnia in Early Childhood

Role: lead

NCT05692011Recruiting

AN69ST Verse PS in CBP in Septic Children

Role: collaborator

NCT05595239Not ApplicableNot Yet Recruiting

Blood Purification in Septic Children

Role: collaborator

NCT07405658Not Yet Recruiting

Clinical Study on an Artificial Intelligence-Assisted Chest Radiograph Model Based on Big Data and Deep Learning for Early Detection of Kawasaki Disease

Role: collaborator

NCT06850220Recruiting

Observational Study on the Impact of Obstructive Sleep Apnea on Executive Function and Empathy Development in Children

Role: lead

NCT06489951Not ApplicableCompleted

Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic Biomarker

Role: collaborator

NCT07184281Not ApplicableRecruiting

Effectiveness of School-Based Time-Restricted Eating for the Prevention and Control of Obesity in Children

Role: lead

NCT07168980Phase 2Recruiting

Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents

Role: collaborator

NCT07038538Not ApplicableRecruiting

Evidence-based Practice in the Management of Gastric Tube Placement in Children

Role: collaborator

NCT03255694Phase 2Active Not Recruiting

A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

Role: collaborator

NCT06827249Not ApplicableRecruiting

Peginterferon α-2b Injection for the Treatment of Pediatric RSV Bronchiolitis

Role: lead

NCT06673459Phase 3Not Yet Recruiting

BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients

Role: collaborator

NCT06221683Phase 2Recruiting

Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML

Role: lead

NCT06316960Phase 2Recruiting

Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation

Role: lead

NCT06381817Phase 3Recruiting

Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients

Role: collaborator

NCT05184621Not ApplicableCompleted

The Effectiveness and Safety of Low-intensity Single-wavelength Red Light in Controlling High Myopia in Children and Adolescents:A Randomized, Controlled, Multicenter Clinical Trial

Role: collaborator